Search

everythinglearnresearchcommunity

for

Search:↓

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

Studying rare genetic disorders can help us understand and treat common diseases better.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Ca_v1.2 affects hair growth and could be a target for hair loss treatments.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

The STIM1 R304W mutation in mice leads to bone changes and teeth hair growth.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

CaV1.2 helps activate hair follicle stem cells without calcium flux.

Cantú syndrome is caused by mutations in the ABCC9 gene.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

CaBP1 and CaBP2 are necessary for proper hearing and neurotransmission in the ear's inner hair cells.

CaBP1 and CaBP2 are necessary for proper hearing and neurotransmission in the ear's inner hair cells.

CaBP1 and 2 are important for maintaining the activity of calcium channels necessary for hearing in inner ear cells.